logo
  1. Home
  2. Stocks
  3. Zydus Lifesciences

Zydus Lifesciences Share Price

Mid Cap | Pharmaceuticals and health care | NSE: ZYDUSLIFE | BSE: 532321

₹866.90 image-35.00 (-3.88 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 901.90

High (₹) 905.95

Low (₹) 834.50

Prev. Close (₹) 901.90

Volume 32,87,190

VWAP (₹) 876.68

ROCE (%) 20.48

Industry P/E 44.73

TTM P/E 18.66

P/B Ratio 3.95

Market Cap (₹) Cr.87,230.42

Dividend Yield (%)0.35

EPS (₹) 38.14

ROE17.36%

Sales Growth (%) 13.40

Profit Growth (%)92.98

Day Range

905.95905.95

L
H

52 Week Range

834.651,323.90

L
H

Historical Returns

Returns (6M)

-17.49 %

Returns (1Y)

-13.87 %

Returns (3Y)

134.61 %

Returns (5Y)

177.54 %

Returns (6M)

-17.49 %

Returns (1Y)

-13.87 %

Returns (3Y)

134.61 %

Returns (5Y)

177.54 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (97.62%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 97.62% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 34.44

MFI 23.87

ATR 30.01

Commodity Channel Index -100.49

ROC125 -22.57

ROC21 -8.06

Williams %R -85.00

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current886.70896.80906.60876.90866.80857.00846.90
Week Ago900.50915.65924.90891.25876.10866.85851.70
Month Ago924.85939.45956.30908.00893.40876.55861.95

EMA & SMA
info_icon

866.90

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 884.80

9 Day 900.48

10 Day 896.53

12 Day 910.83

14 Day 917.12

20 Day 935.68

26 Day 935.44

50 Day 956.67

100 Day 975.01

200 Day 1046.02

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
UBS PRINCIPAL CAPITAL ASIA LIMITEDbulkSell30 Aug, 2024₹1,128.1167,01,664NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
29 Mar, 2024DEVAL DHIRAJBHAI SHAHDisposal₹1,006.64292NSE
29 Mar, 2024DEVAL DHIRAJBHAI SHAHRevoke₹1,005.25292NSE
29 Mar, 2024Zydus Family TrustDisposal₹1,006.6810,000NSE
29 Mar, 2024Zydus Family TrustDisposal₹1,010.6230,000NSE
28 Mar, 2024Zydus Family TrustDisposal₹1,008.665,65,466NSE
28 Mar, 2024Zydus Family TrustDisposal₹1,015.3517,534NSE
28 Mar, 2024DEVAL DHIRAJBHAI SHAHDisposal₹1,010.92150NSE
28 Mar, 2024DEVAL DHIRAJBHAI SHAHDisposal₹985.57500NSE
28 Mar, 2024DEVAL DHIRAJBHAI SHAHRevoke₹999.50500NSE
28 Mar, 2024DEVAL DHIRAJBHAI SHAHRevoke₹1,018.10150NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
17 May, 2024Rs.3.0000 per share(300%)Final Dividend26 Jul, 202426 Jul, 2024
18 May, 2023Rs.6.0000 per share(600%)Final Dividend28 Jul, 202328 Jul, 2023
20 May, 2022Rs.2.5000 per share(250%)Final Dividend28 Jul, 202229 Jul, 2022

Announcements

DateSourceDetail
28 Mar, 2025NSE IndiaZYDUS LIFESCIENCES LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
28 Mar, 2025BSE IndiaUpdate on acquisition of a business
28 Mar, 2025NSE IndiaZydus Lifesciences Limited has informed the Exchange about General Updates
28 Mar, 2025NSE IndiaZydus Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
25 Mar, 2025NSE IndiaZYDUS LIFESCIENCES LIMITED has informed the Exchange about Closure of Trading Window
25 Mar, 2025NSE IndiaZydus Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
18 Mar, 2025BSE IndiaZydus receives final approval from USFDA for Apalutamide Tablets, 60 mg.
18 Mar, 2025NSE IndiaZydus Lifesciences Limited has informed the Exchange regarding a press release dated March 18, 2025, titled ""Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg"".
16 Mar, 2025BSE IndiaZydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg.
16 Mar, 2025NSE IndiaZydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2025, titled ""Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg"".

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--22 Jan, 202505 Feb, 2025
Quarterly Results--31 Oct, 202412 Nov, 2024
Quarterly Results--19 Jul, 202409 Aug, 2024
Audited Results & Final Dividend--10 May, 202417 May, 2024
Quarterly Results & Buy Back of shares--07 Feb, 202409 Feb, 2024
Quarterly Results--31 Oct, 202307 Nov, 2023
Quarterly Results--02 Aug, 202311 Aug, 2023
Audited Results & Final Dividend--15 May, 202318 May, 2023
Quarterly Results--24 Jan, 202303 Feb, 2023
Quarterly Results--31 Oct, 202211 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group74.98%74.98%74.98%74.88%74.88%
Foreign Institutions +7.53%4.99%2.52%3.79%5.24%
Domestic Institutions +10.66%13.03%13.68%11.81%11.72%
Government0%0%0%0%0%
Public6.83%7%8.82%9.52%8.16%
Others0%0%0%0%0%

About Zydus Lifesciences

Zydus Lifesciences is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 10818.70 Cr. and Equity Capital is Rs. 100.60 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Zydus Cadilla Group

Founded

1995

Managing Director

Dr. Sharvil P Patel

NSE Symbol

ZYDUSLIFE

Zydus Lifesciences Management

NameDesignation
Mr. Pankaj R PatelChairman
Dr. Sharvil P PatelManaging Director
Mr. Ganesh N NayakExecutive Director
Mr. Mukesh M PatelNon Executive Director
Mr. Bhadresh K ShahIndependent Director
Ms. Apurva S DiwanjiIndependent Director
Mr. Monappa Arun AkhilIndependent Director
Mrs. Upasana KonidelaIndependent Woman Director
Ms. Shelina P ParikhIndependent Woman Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Zydus Lifesciences

What is the share price of Zydus Lifesciences?

The share price of Zydus Lifesciences on 04 Apr, 2025 is ₹ 866.90.

What is 52W high and 52W low share price of Zydus Lifesciences?

The highest and lowest 52W share prices of Zydus Lifesciences are ₹ 1323.900 and ₹ 859.150

What is the market cap of Zydus Lifesciences?

The market capitalization of Zydus Lifesciences as of 04 Apr, 2025 is ₹ 87,230.42 Crores

What is the P/E ratio of Zydus Lifesciences?

The current P/E ratio of Zydus Lifesciences as of 04 Apr, 2025 is 44.73

What is the PB ratio of Zydus Lifesciences?

The PB ratio of Zydus Lifesciences as of 04 Apr, 2025 is 3.95

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited